Time dependent enhanced resistance against antibiotics & metal salts by planktonic & biofilm form of Acinetobacter haemolyticus MMC 8 clinical isolate

Indian Journal of Medical Research

Volumn 140, Issue , 2014, Pages 665-671

  Gaidhani, Sharvari Vijaykumar ^a   Raskar, Aartee Vishnu ^a   Poddar, Sharmishtha ^a   Gosavi, Shriya ^a   Sahu, Praveen Kishore ^a   Pardesi, Karishma Rajendra ^a   Bhide, Shobhana V ^a   Chopade, Balu Ananada ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

Acinetobacter haemolyticus; Antibiotic resistance; Calgary biofilm device; MBIC; MIC; Persister cells; SEM

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; GENTAMICIN; IMIPENEM; KANAMYCIN; LOMEFLOXACIN; MERCURIC CHLORIDE; MEROPENEM; METAL; NETILMICIN; PENICILLIN G; POLYMYXIN B; RIFAMPICIN; SILVER NITRATE; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; INORGANIC SALT;

ACINETOBACTER; ACINETOBACTER HAEMOLYTICUS; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BIOFILM; BROTH DILUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; MICROTITER PLATE ASSAY; MINIMUM BIOFILM INHIBITING CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; SCANNING ELECTRON MICROSCOPY; TIME; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; HUMANS; METALS; MICROBIAL SENSITIVITY TESTS; PLANKTON; SALTS;

EID: 84920477640     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Patwardhan RB, Dhakephalkar PK, Niphadkar KB, Chopade BA. A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids. Indian J Med Res 2008; 128: 178-87.
2. Dijkshoorn LA, Nemec A, Seifert H. An increasing threat in hospitals: multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-51.
3. Yavankar S, Pardesi KR, Chopade BA. Species distribution and physiological characterization of Acinetobacter genospecies isolated from healthy human skin of tribal population of India. Indian J Med Microbiol 2007; 25: 336-45.
4. Baur AW, Kirby WMM, Sherris JC, Turk M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
5. Gospodarek E, Kania I. Occurrence of species from Acinetobacter genus in clinical material and other sources. Med Dosw Mikrobiol 1992; 44: 41-8.
6. Tjenberg I. Antimicrobial susceptibility of Acinetobacter strains identifed by DNA-DNA hybridization. Acta Pathol Microbial Immunol Scand 1990; 98: 320-6.
7. Quinteira S, Grosso F, Ramos H, Peixe L. Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a portuguese hospital. Antimicrob Agents Chemother 2007; 51: 3465-6.
8. Traub WH, Spohr M. Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3 and genospecies 6). Antimcrob Agents Chemother 1989; 33: 1617-9.
9. Grotiuz G, Sirok A, Gadea P, varela G, Schelotto F. Shiga toxin 2-producing Acinetobacter haemolyticus associated with a case of bloody diarrhea. J Clin Microbiol 2006; 44: 3838-41.
10. Stewart PS. Mechanisms of antibiotic resistance in bacterial bioflims. Int J Med Microbiol 2002; 292: 107-13.
11. Cerca N, Martins S, Cerca F, Jefferson KK, Pier G B, Oliveira R, et al. Comparative assessment of antibiotic susceptibility of coagulase negative staphylococcal bioflim versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005; 56: 331-6.
12. Ito A, Taniuchi A, May T, Kawata K, Okabe S. Increased antibiotic resistance of Escherichia coli mature bioflim. App Env Microbiol 2009; 75: 4093-100.
13. Spoering AL, Lewis K. Bioflims and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001; 183: 6746-51.
14. Nishimura S, Toshiyuki T, Akihiko Y, Koichi A, Hiroyuki S. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis bioflims isolated from infected total hip arthroplasty cases. J Orthop Sci 2006; 11: 46-50.
15. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial bioflims. Int J Antimicrob Agents 2010; 35: 322-32.
16. Harrison JJ, Ceri H, Turner RJ. Multimetal resistance and tolerance in microbial bioflims. Nature 2007; 5: 928-38.
17. Clinical Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards. 9th ed. CLSI Document M07-A9. Wayne, PA, USA: CLSI; 2012.
18. Deshpande LM, Chopade BA. Plasmid mediated silver resistance in Acinetobacter baumannii BL54. BioMetals 1994; 7: 49-56.
19. Sahu PK, Iyer PS, Oak AM, Pardesi KR, Chopade BA. Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in bioflim formation. Sci World J 2012; doi:10.1100/2012/973436.
20. Nancharaiah YV, venugopalan VP, Wuertz S, Wilderer PA, Hausner M. Compatibility of the green fuorescent proteins and a general nucleic acid stain for quantitative description of a Pseudomonas putida bioflim. J Microbiol Methods 2005; 60: 179-87.
21. Anwar H, Costerton JW. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile bioflim cells of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34: 1666-71.
22. Harrison JJ, Ceri H, Stremick CA, Turner RJ. Bioflim susceptibility to metal toxicity. Environ Microbiol 2004; 6: 1220-7.
23. Teitzel GM, Parsek MR. Heavy metal resistance of bioflim and planktonic Pseudomonas aeruginosa. App Environ Microbiol 2003; 69: 2313-20.
24. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae bioflim resistant to ampicillin and ciprofoxacin. Antimicrob Agents Chemother 2000; 44: 1818-24.
25. Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M, et al. Alginate overproduction affects Pseudomonas aeruginosa bioflim structure and function. J Bacteriol 2001; 183: 5395-401.
26. Sutherland IW. The bioflim matrix-an immobilized but dynamic microbial environment. Trends Microbiol 2009; 9: 222-7.
27. Whitchurch CB, Tolker-Neilsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial bioflim formation. Science 2002; 295: 1487.
28. Wozniak DJ, Wycoff TO, Starkey M, Keyser R, Azadi P, O’Toole GA, et al. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa bioflims. Proc Natl Acad Sci USA 2003; 100: 7907-12.
29. Rani SA, Pitts B, Beyenal H, Veluchamy RA, Lewandowski Z, Davison WM, et al. Spatial patterns of DNA replication, protein synthesis and oxygen concentration within bacterial bioflims reveal diverse physiological states. J Bacteriol 2007; 189: 4223-33.
30. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa bioflims. Microb Infect 2003; 5: 1213-9.
31. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004; 230: 13-8.
32. Singh R, Ray P, Das A, Sharma M. Role of persisters and small colony variants in antibiotic resistance of planktonic and bioflim associated Staphylococcus aureus: an in vitro study. J Med Microbiol 2009; 58: 1067-73.
33. Harrison JJ, Ceri H, Roper NJ, Badry EA, Sproule KM, Turner RJ. Persister cells mediate tolerance to metal oxyanions in Escherichia coli. Microbiology 2009; 151: 3181-95.
34. Brooun A, Liu S, Lewis K. A dose response study of antibiotic in Pseudomonas aeruginosa bioflims. Antimicrob Agents Chemother 2000; 44: 640-6.